---
title: "HANDLER released its first-quarter performance, with a net profit attributable to the parent company of 28.6385 million yuan, an increase of 26.71%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236811151.md"
description: "HANDLER released its Q1 2025 performance report, with operating revenue of 346 million yuan, a year-on-year increase of 54.80%; net profit attributable to the parent company of 28.6385 million yuan, a year-on-year increase of 26.71%; net profit after deducting non-recurring gains and losses of 28.5044 million yuan, a year-on-year increase of 40.66%; basic earnings per share of 0.0304 yuan"
datetime: "2025-04-21T14:08:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236811151.md)
  - [en](https://longbridge.com/en/news/236811151.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236811151.md)
generator: "portal-rs"
---

# HANDLER released its first-quarter performance, with a net profit attributable to the parent company of 28.6385 million yuan, an increase of 26.71%

According to the Zhitong Finance APP, HANDLER (300201.SZ) released its first quarter report for 2025, with operating revenue of 346 million yuan, a year-on-year increase of 54.80%. The net profit attributable to shareholders of the listed company was 28.6385 million yuan, a year-on-year increase of 26.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 28.5044 million yuan, a year-on-year increase of 40.66%. The basic earnings per share were 0.0304 yuan

### Related Stocks

- [300201.CN](https://longbridge.com/en/quote/300201.CN.md)

## Related News & Research

- [FTON: Strong revenue and profit growth in H1 2026, with strategic expansion and solid outlook](https://longbridge.com/en/news/297125712.md)
- [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md)
- [Sappi, UPM propose graphic paper joint venture](https://longbridge.com/en/news/297161466.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**